1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Fagan Associates, Inc. Buys Advanced Micro Devices Inc, Sarepta Therapeutics Inc, Boston Scientific Corp, Sells Regeneron Pharmaceuticals Inc, Take-Two Interactive Software Inc, The Mosaic Co

Troy, NY, based Investment company Fagan Associates, Inc. (current portfolio) buys Advanced Micro Devices Inc, Sarepta Therapeutics Inc, Boston Scientific Corp, Chevron Corp, AT&T Inc, sells Regeneron Pharmaceuticals Inc, Take-Two Interactive Software Inc, The Mosaic Co, New Relic Inc, Bristol-Myers Squibb Company during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Fagan Associates, Inc.. As of 2019Q2, Fagan Associates, Inc. owns 111 stocks with a total value of $246 million. These are the details of the buys and sells.

For the details of FAGAN ASSOCIATES, INC.'s stock buys and sells, go to https://www.gurufocus.com/guru/fagan+associates%2C+inc./current-portfolio/portfolioportfolio

These are the top 5 holdings of FAGAN ASSOCIATES, INC.
  1. Apple Inc (AAPL) - 74,427 shares, 5.99% of the total portfolio. Shares added by 2.02%
  2. Microsoft Corp (MSFT) - 97,770 shares, 5.33% of the total portfolio. Shares added by 1.22%
  3. Alphabet Inc (GOOGL) - 10,779 shares, 4.75% of the total portfolio. Shares added by 1.35%
  4. Mastercard Inc (MA) - 34,527 shares, 3.72% of the total portfolio. Shares added by 0.06%
  5. Facebook Inc (FB) - 46,313 shares, 3.64% of the total portfolio. Shares added by 3.51%
New Purchase: Advanced Micro Devices Inc (AMD)

Fagan Associates, Inc. initiated holding in Advanced Micro Devices Inc. The purchase prices were between $26.24 and $33.23, with an estimated average price of $28.48. The stock is now traded at around $33.21. The impact to a portfolio due to this purchase was 0.78%. The holding were 63,470 shares as of .

New Purchase: Sarepta Therapeutics Inc (SRPT)

Fagan Associates, Inc. initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $112.21 and $151.95, with an estimated average price of $121.45. The stock is now traded at around $156.10. The impact to a portfolio due to this purchase was 0.38%. The holding were 6,170 shares as of .

New Purchase: CyrusOne Inc (CONE)

Fagan Associates, Inc. initiated holding in CyrusOne Inc. The purchase prices were between $52.73 and $63.72, with an estimated average price of $58.64. The stock is now traded at around $58.89. The impact to a portfolio due to this purchase was 0.11%. The holding were 4,505 shares as of .

New Purchase: Omega Healthcare Investors Inc (OHI)

Fagan Associates, Inc. initiated holding in Omega Healthcare Investors Inc. The purchase prices were between $34.95 and $38.16, with an estimated average price of $36.45. The stock is now traded at around $36.96. The impact to a portfolio due to this purchase was 0.1%. The holding were 6,640 shares as of .

New Purchase: iShares Core S&P Total U.S. Stock Market (ITOT)

Fagan Associates, Inc. initiated holding in iShares Core S&P Total U.S. Stock Market. The purchase prices were between $62.13 and $66.91, with an estimated average price of $65.23. The stock is now traded at around $68.22. The impact to a portfolio due to this purchase was 0.09%. The holding were 3,155 shares as of .

New Purchase: American Express Co (AXP)

Fagan Associates, Inc. initiated holding in American Express Co. The purchase prices were between $109.85 and $124.92, with an estimated average price of $117.43. The stock is now traded at around $127.96. The impact to a portfolio due to this purchase was 0.08%. The holding were 1,660 shares as of .

Added: Boston Scientific Corp (BSX)

Fagan Associates, Inc. added to a holding in Boston Scientific Corp by 34.56%. The purchase prices were between $34.91 and $42.98, with an estimated average price of $38.41. The stock is now traded at around $42.25. The impact to a portfolio due to this purchase was 0.16%. The holding were 36,680 shares as of .

Added: Chevron Corp (CVX)

Fagan Associates, Inc. added to a holding in Chevron Corp by 33.83%. The purchase prices were between $113.85 and $126.68, with an estimated average price of $120.87. The stock is now traded at around $125.98. The impact to a portfolio due to this purchase was 0.13%. The holding were 10,029 shares as of .

Added: AT&T Inc (T)

Fagan Associates, Inc. added to a holding in AT&T Inc by 21.00%. The purchase prices were between $30.3 and $33.51, with an estimated average price of $31.77. The stock is now traded at around $33.65. The impact to a portfolio due to this purchase was 0.12%. The holding were 51,268 shares as of .

Added: StoneCo Ltd (STNE)

Fagan Associates, Inc. added to a holding in StoneCo Ltd by 36.18%. The purchase prices were between $24.69 and $42.93, with an estimated average price of $29.32. The stock is now traded at around $33.82. The impact to a portfolio due to this purchase was 0.07%. The holding were 22,245 shares as of .

Added: Granite Construction Inc (GVA)

Fagan Associates, Inc. added to a holding in Granite Construction Inc by 73.78%. The purchase prices were between $40.03 and $48.18, with an estimated average price of $43.71. The stock is now traded at around $43.38. The impact to a portfolio due to this purchase was 0.07%. The holding were 8,385 shares as of .

Added: iShares Core U.S. Aggregate Bond (AGG)

Fagan Associates, Inc. added to a holding in iShares Core U.S. Aggregate Bond by 20.80%. The purchase prices were between $107.29 and $111.16, with an estimated average price of $108.84. The stock is now traded at around $110.79. The impact to a portfolio due to this purchase was 0.05%. The holding were 6,261 shares as of .

Sold Out: Regeneron Pharmaceuticals Inc (REGN)

Fagan Associates, Inc. sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $299.6 and $414.82, with an estimated average price of $332.61.

Sold Out: Take-Two Interactive Software Inc (TTWO)

Fagan Associates, Inc. sold out a holding in Take-Two Interactive Software Inc. The sale prices were between $89.74 and $113.83, with an estimated average price of $102.76.

Sold Out: The Mosaic Co (MOS)

Fagan Associates, Inc. sold out a holding in The Mosaic Co. The sale prices were between $21.27 and $27.92, with an estimated average price of $24.41.

Sold Out: New Relic Inc (NEWR)

Fagan Associates, Inc. sold out a holding in New Relic Inc. The sale prices were between $86.51 and $108.45, with an estimated average price of $98.73.

Sold Out: Fluor Corp (FLR)

Fagan Associates, Inc. sold out a holding in Fluor Corp. The sale prices were between $27.72 and $41.56, with an estimated average price of $33.55.

Sold Out: Bristol-Myers Squibb Company (BMY)

Fagan Associates, Inc. sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $44.62 and $49.34, with an estimated average price of $46.57.



Here is the complete portfolio of FAGAN ASSOCIATES, INC.. Also check out:

1. FAGAN ASSOCIATES, INC.'s Undervalued Stocks
2. FAGAN ASSOCIATES, INC.'s Top Growth Companies, and
3. FAGAN ASSOCIATES, INC.'s High Yield stocks
4. Stocks that FAGAN ASSOCIATES, INC. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)